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ABSTRACT
Chediak Higashi syndrome (CHS) is a rare autosomal recessive immunodeficiency disorder that arises due to the mutation of a 
trafficking protein which leads to a decrease in phagocytosis. This results in frequent pyogenic infections, albinism, and peripheral 
neuropathy. Infections in these patients tend to be very serious and life-threatening. CHS is caused by mutations in a gene LYST on 
chromosome 1. Here, we report the case of CHS in a 4-year-old boy who presented to us with recurrent fever, splenomegaly, and 
hypopigmentation. This case is being presented due to its rarity and presentation of pancytopenia without hemophagocytosis.
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Chediak Higashi syndrome (CHS) is a rare autosomal recessive multisystem disorder characterized by partial oculocutaneous albinism, frequent pyogenic infections, 
febrile episodes, pigmentation, easy bruisability and abnormally 
large granules in all granule containing cells [1]. This syndrome 
affects the immune system and the nervous system. Peripheral 
neuropathy is often seen as neurologic involvement. Death usually 
occurs at an early age due to infection or bleeding. CHS is caused 
by mutations in gene LYST at chromosome locus 1q42.1-q42.2.
CASE REPORT  
A 4-year-old boy, born out of non-consanguineous marriage 
presented to the hospital with a history of generalized body 
weakness, loss of appetite, fever, and rashes all over the body 
for2 years. A past history of frequent infections was present. The 
child had multiple episodes of respiratory and gastrointestinal 
tract infections in the past 3 years.
Physical Examination revealed severe pallor, silvery grey 
hair, generalized hypopigmentation and splenomegaly. There was 
no hepatomegaly, lymphadenopathy and peripheral neuropathy 
(Fig. 1). Fundus examination revealed pink fundus with elevated 
disc margins and alternating hypo and hyperpigmented patches. 
Heterochromia iridis was seen. Nystagmus was present.
A complete blood count showed pancytopenia (hemoglobin 
of 4.1gm/dl, total WBC count of 1280/cumm with lymphocyte 
predominance) and platelet count of 28000/ul. Large pink 
granules in granulocytes and magenta coloured intracytoplasmic 
inclusions in monocytes were seen in bone marrow aspirate smears 
(Fig. 2). There was no evidence of haemophagocytosis. Bone 
marrow biopsy revealed normocellular erythroid preponderant 
marrow exhibiting trilineage hematopoiesis with prominent large 
intracytoplasmic granules in granulocytes and monocytes (Fig. 3). 
A diagnosis of CHS was made based on combined clinical and 
laboratory findings. The child was treated with antibiotics and 
steroids.
Figure 1: (a) A 4-year-old male child with splenomegaly; (b) silver-
grey hair with hypopigmentation.
Figure 2: Bone marrow aspirate; 1000x- large pink granules in 
granulocytes.
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DISCUSSION
CHS was first described by Bequez-Cesar in 1943 in 3 siblings 
having the same clinical features [1]. Chediak, a Cuban 
hematologist in 1952 and in 1954 Higashi, a Japanese pediatrician 
found maldistribution of myeloperoxidase in neutrophilic 
granules of affected patients [1]. 
Mutations in LYST/ CHS1 gene on chromosome 
1q42.1-q42.2 which is important for regulating the biosynthesis 
of lysosomes result in CHS [2]. Till date, 40 mutations have 
been identified in this gene. The protein encoded by this gene 
prevents the fusion of lysosomes with other intracellular 
membrane vesicles [3].
CHS is a disease of infancy and early childhood. The mean age 
of onset is 5.85 years; however, most patients die before age 10 
years. Our present case was a child aged 4 years old. The clinical 
features and laboratory findings were consistent with CHS. 
Clinical features such as silver-grey hair with partial cutaneous 
albinism, organomegaly were present in our case.
An abnormal truncated protein formed due to missense/
frameshift mutation of CHS1 gene results in defective granule 
morphogenesis in several tissues.A neutrophil is the most 
extensively studied affected cell. It has been seen that in addition 
to giant granules in the cytoplasm, neutrophils are deficient in 
neutral proteases and Cathepsin G and Elastase. Defective 
degranulation, decreased bactericidal activity and defective 
chemotaxis of monocytes cause recurrent infections. The child 
presented in this case analysis also had recurrent episodes of 
infection which is the result of a decrease in phagocytosis [4,5]. 
Ineffective myelopoiesis results in neutropenia in several patients 
with CHS. Defective T/natural killer cell function results in the 
development of hemophagocytic lymphohistiocytosis (HLH) in 
the accelerated phase of CHS and is sometimes precipitated by 
viral infections e.g. EBV [6].
A stable phase of CHS should be managed by prompt 
treatment and prevention of infections. Most of the patients 
undergo an accelerated phase, which is a non-malignant 
lymphohistiocytic infiltration of multiple organs that occurs 
in more than 80% of the patients. HLH (accelerated phase) is 
treated by immunosuppressive drugs followed by allogeneic 
hematopoietic stem cell transplantation [7].
CONCLUSION
CHS is a disease of infancy and childhood. It affects males and 
females in equal numbers. There are less than 500 cases of the 
disease on record. CHS affects all races. A few cases have been 
reported from India till date. It is recommended that parents 
and siblings of the patients of CHS should be screened for the 
presence of giant granules in the leucocytes. Prenatal diagnosis 
can be done by examination of hair from fetal scalp biopsy 
specimens. The pathologic hallmark is the presence of lysosomal 
inclusions in leucocytes. Careful peripheral blood film and bone 
marrow examination in a child with albinism should be done. 
Allogenic bone marrow transplant is the only curative treatment.
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Figure 3: Bone marrow biopsy; 1000x- large intracytoplasmic 
granules. 
